Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication20122013201420152016201720182019202020212022202320242025 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyClinical Trial UnitProduct Development Apr 2025 Sci Adv Discovery of synthetic small molecules targeting the central regulator of Salmonella pathogenicity Autoren Boudrioua A et al. Apr 2025 Lancet HIV Impact of quasi-elimination of Wuchereria bancrofti on HIV incidence in southwest Tanzania: a 12-year prospective cohort study Autoren Kroidl I et al. Mar 2025 Cell Host Microbe Highly potent quinoxalinediones inhibit α-hemolysin and ameliorate Staphylococcus aureus lung infections Autoren Shekhar A et al. Mar 2025 IJTLD Open Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy Autoren Kuksa L et al. Mar 2025 Health Policy Strengthening Diagnostic Services in Latin America Requires Regional Leadership, Sustainable Funding, and Enhanced Data Sharing Autoren Moreira-Soto A et al. Mar 2025 BMJ Open Socioeconomic determinants potentially underlying differential global SARS-CoV-2 testing capacity: an ecological study Autoren Moreira-Soto A et al. Feb 2025 Nat Commun Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric mice Autoren Ssebyatika G et al. Feb 2025 Am J Transplant Gut microbiome alterations precede graft rejection in kidney transplantation patients Autoren Holle J et al. Feb 2025 J Infect Dis Elucidating Infectious Causes of Fever of Unknown Origin: A Laboratory-Based Observational Study of Patients with Suspected Ebola Virus Disease, Guinea, 2014 Autoren Postigo-Hidalgo I et al. Feb 2025 The Lancet Global Health Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa: an observational study Autoren Fischer C Feb 2025 The Lancet Global Health Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa: an observational study Autoren Fischer C et al. Jan 2025 Epid Bull Vernachlässigte Tropenkrankheiten – Gemeinsam handeln für eine Welt ohne NTDs Autoren Fastenau A et al. Jan 2025 Liver Int Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta Autoren Lampertico P et al. Jan 2025 Nat Commun Reverse mutational scanning of SARS-CoV-2spike BA.2.86 identifies epitopescontributing to immune escape frompolyclonal sera Autoren Bdeir N et al. Jan 2025 Nat Commun The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis Autoren Römpp A et al. Jan 2025 JHEP Rep Adapted hepatitis C virus clone infects innate immunity deficient mouse hepatocytes with minimal human HCV entry factors Autoren Sheldon JA et al. Jan 2025 The Lancet Microbe Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial Autoren Heinrich N et al. Dec 2024 Science Autologous DNA mobilization and multiplication expedite natural products discovery from bacteria Autoren Xie F et al. Dec 2024 EU-LAC Foundation Shared Challenges, Shared Responsibilities: Lessons Learnt for EU-LAC Cooperation in Global Health Autoren Hofmann B et al. Dec 2024 Science Advances Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies Autoren Kumar Nagarathinam et al. Dec 2024 JAMA Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel Autoren Gandhi RT et al. Nov 2024 ACS Infect Dis In Vivo Activity Profiling of Biosynthetic Darobactin D22 Against Critical Gram-Negative Pathogens Autoren Kany AM et al. Oct 2024 BMC Infect Dis Resistance of Anopheles gambiae s.s. against commonly used insecticides and implication of cytochrome P450 monooxygenase in resistance to pyrethroids in Lambaréné (Gabon) Autoren Boussougou-Sambe ST et al. Oct 2024 Infection Characterising HIV-Indicator conditions among two nationwide long-term cohorts of people living with HIV in Germany (1999-2023) Autoren Krings A et al. Oct 2024 Nucleic Acids Res BGC Atlas: a web resource for exploring the global chemical diversity encoded in bacterial genomes Autoren Bağcı C et al. Pagination < Zurück Current page 1 Seite 2 Seite 3 Seite 4 Seite 5 Seite 6 Seite 7 Seite 8 Seite 9 Seite 1 Seite 2 Seite 3 Seite 4 Seite 5 Seite 6 Seite 7 Seite 8 Seite 9 Next page ››
Apr 2025 Sci Adv Discovery of synthetic small molecules targeting the central regulator of Salmonella pathogenicity Autoren Boudrioua A et al.
Apr 2025 Lancet HIV Impact of quasi-elimination of Wuchereria bancrofti on HIV incidence in southwest Tanzania: a 12-year prospective cohort study Autoren Kroidl I et al.
Mar 2025 Cell Host Microbe Highly potent quinoxalinediones inhibit α-hemolysin and ameliorate Staphylococcus aureus lung infections Autoren Shekhar A et al.
Mar 2025 IJTLD Open Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy Autoren Kuksa L et al.
Mar 2025 Health Policy Strengthening Diagnostic Services in Latin America Requires Regional Leadership, Sustainable Funding, and Enhanced Data Sharing Autoren Moreira-Soto A et al.
Mar 2025 BMJ Open Socioeconomic determinants potentially underlying differential global SARS-CoV-2 testing capacity: an ecological study Autoren Moreira-Soto A et al.
Feb 2025 Nat Commun Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric mice Autoren Ssebyatika G et al.
Feb 2025 Am J Transplant Gut microbiome alterations precede graft rejection in kidney transplantation patients Autoren Holle J et al.
Feb 2025 J Infect Dis Elucidating Infectious Causes of Fever of Unknown Origin: A Laboratory-Based Observational Study of Patients with Suspected Ebola Virus Disease, Guinea, 2014 Autoren Postigo-Hidalgo I et al.
Feb 2025 The Lancet Global Health Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa: an observational study Autoren Fischer C
Feb 2025 The Lancet Global Health Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa: an observational study Autoren Fischer C et al.
Jan 2025 Epid Bull Vernachlässigte Tropenkrankheiten – Gemeinsam handeln für eine Welt ohne NTDs Autoren Fastenau A et al.
Jan 2025 Liver Int Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta Autoren Lampertico P et al.
Jan 2025 Nat Commun Reverse mutational scanning of SARS-CoV-2spike BA.2.86 identifies epitopescontributing to immune escape frompolyclonal sera Autoren Bdeir N et al.
Jan 2025 Nat Commun The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis Autoren Römpp A et al.
Jan 2025 JHEP Rep Adapted hepatitis C virus clone infects innate immunity deficient mouse hepatocytes with minimal human HCV entry factors Autoren Sheldon JA et al.
Jan 2025 The Lancet Microbe Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial Autoren Heinrich N et al.
Dec 2024 Science Autologous DNA mobilization and multiplication expedite natural products discovery from bacteria Autoren Xie F et al.
Dec 2024 EU-LAC Foundation Shared Challenges, Shared Responsibilities: Lessons Learnt for EU-LAC Cooperation in Global Health Autoren Hofmann B et al.
Dec 2024 Science Advances Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies Autoren Kumar Nagarathinam et al.
Dec 2024 JAMA Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel Autoren Gandhi RT et al.
Nov 2024 ACS Infect Dis In Vivo Activity Profiling of Biosynthetic Darobactin D22 Against Critical Gram-Negative Pathogens Autoren Kany AM et al.
Oct 2024 BMC Infect Dis Resistance of Anopheles gambiae s.s. against commonly used insecticides and implication of cytochrome P450 monooxygenase in resistance to pyrethroids in Lambaréné (Gabon) Autoren Boussougou-Sambe ST et al.
Oct 2024 Infection Characterising HIV-Indicator conditions among two nationwide long-term cohorts of people living with HIV in Germany (1999-2023) Autoren Krings A et al.
Oct 2024 Nucleic Acids Res BGC Atlas: a web resource for exploring the global chemical diversity encoded in bacterial genomes Autoren Bağcı C et al.
